From the March 30, 2020, edition of Fox News' Fox & Friends

PRESIDENT DONALD TRUMP: We're doing really very good with the vaccines, but that's not for right now. In the meantime, you have people -- I have friends in the hospital. I have one of them who’s got two problems, he's heavy and he's not so young, OK? He’s not exactly a youngster and he's in a coma, so, you know, this is tough stuff. So the hydroxychloroquine is something that I have been pushing very hard. I got the very early approval from the FDA, it was going to take a long time, and Dr. Steven Hahn, the head of the FDA, gave us an early approval, a very quick approval, a 24-hour approval. I mean, it was incredible. Because the drug has been used and the other with the Z-pak, azithromycin, it’s called Z-pak, azithromycin, and the combination. And I think it might be successful. 

Now here's the only problem. I'll know — I think that we'll have have a good idea over the next three days because its been used now in New York at my request, 1,100 people, it’s been used, I think that's better than testing in a laboratory, but you know the doctors tell me no, some doctors tell me no, but whatever it is it is. And I got it done because I said look some of these people are very sick and they're not going to make it let's do it. Let's get it done. It's like right to try. I got that approved where people are now — that was trying to get approved for 50 years. They couldn't — I got it done. Where people that were terminally ill weren't allowed to use potentially good drugs because they weren't approved. So I now have it where they can use them. And by the way, the results have been unbelievable. They’ve traveled to Asia, they’ve traveled to Europe to get drugs, and, you know, we gave them hope, but it's more than hope because these drugs are in many cases they've been working and saving lives. It’s been a great thing — it's called right to try. Well this is sort of that. Somebody's really sick or dying, and we try this, and I can tell you, it's a big sample. 1,100 people, and let's see what happens. We're going to start knowing about this stuff in the very, very near future — very near.